MAPK13 CLIA Kit

Produktnummer ABIN6200977

Produktdetails MAPK13 CLIA Kit

Target: MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Untere Nachweisgrenze: 0.156 ng/mL

Applikation: ELISA

Verwendungszweck: Human Mitogen Activated Protein Kinase 13 (MAPK13) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.

Proben: Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 0.061 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))

Andere Bezeichnung: Mitogen Activated Protein Kinase 13 (MAPK13) (MAPK13 Produkte)

Synonyme: F24B9.3 CLIA Kit, F24B9_3 CLIA Kit, MAPK 13 CLIA Kit, MAPK-13 CLIA Kit, PRKM13 CLIA Kit, SAPK4 CLIA Kit, p38delta CLIA Kit, Serk4 CLIA Kit, Prkm13 CLIA Kit, sapk4 CLIA Kit, prkm13 CLIA Kit, Protein kinase superfamily protein CLIA Kit, mitogen-activated protein kinase 13 CLIA Kit, mitogen activated protein kinase 13 CLIA Kit, ATMPK13 CLIA Kit, MAPK13 CLIA Kit, Mapk13 CLIA Kit, mapk13 CLIA Kit

Pathways: MAPK Signalweg, Neurotrophin Signalübertragung, Hepatitis C, BCR Signaling, S100 Proteine